Cart
sales@molnova.com
GW 9508
CAS No. 885101-89-3
GW 9508( GW9508 | GW-9508 | GW 9508 )
Catalog No. M16407 CAS No. 885101-89-3
GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 28 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 73 | In Stock |
|
| 100MG | 133 | In Stock |
|
| 200MG | 197 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGW 9508
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
-
DescriptionGW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, stimulates insulin secretion in a glucose-sensitive manner.
-
In Vitro——
-
In Vivo——
-
SynonymsGW9508 | GW-9508 | GW 9508
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR120| GPR40(FFA1)
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number885101-89-3
-
Formula Weight347.41
-
Molecular FormulaC22H21NO3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 69 mg/mL (198.61 mM); DMSO: 69 mg/mL (198.61 mM)
-
SMILESO=C(O)CCC1=CC=C(NCC2=CC=CC(OC3=CC=CC=C3)=C2)C=C1
-
Chemical Name3-(4-((3-phenoxybenzyl)amino)phenyl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Briscoe CP, et al. Br J Pharmacol, 2006, 148(5), 619-628.
molnova catalog
related products
-
IBC 293
IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
-
AMG 837 calcium hydr...
AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM. AMG 837 calcium hydrate also shows highly selective over GPR41, GPR43, and GPR120 (EC50 > 10,000 nM).
-
2-(pentylsulfanyl)py...
2-(pentylsulfanyl)pyrimidine-4,6-diol is a novel GRP84 agonist.
